Video

The Same Deviation Again? Dig Deeper

Source: Outsourced Pharma

This segment of the Outsourced Pharma Live event, “Your CDMO Quality Oversight Is Not Working,” explores why recurring deviations can expose weaknesses in both a CDMO’s investigations and a sponsor’s oversight. Andrea and Greg discuss why repeated findings of human error deserve scrutiny, how limited resources and insufficient cross-functional input weaken root cause analysis, and when sponsors need to take a more active role in driving effective corrective and preventive actions. Featuring Andrea Goddard, CTO, CatalYm GmbH, and Greg Whitehead, EVP/CTO, Editas Medicine.

Access The Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma